This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2006 Mar;10(3):337-40.

doi: 10.1016/j.gassur.2005.08.026.

Therapeutic and palliative options for diffuse neuroendocrine metastatic disease

Kyle Holen¹

Affiliations

PMID: 16622986
DOI: 10.1016/j.gassur.2005.08.026

Review

Therapeutic and palliative options for diffuse neuroendocrine metastatic disease

Kyle Holen. J Gastrointest Surg. 2006 Mar.

. 2006 Mar;10(3):337-40.

doi: 10.1016/j.gassur.2005.08.026.

Author

Kyle Holen¹

Affiliation

¹ University of Wisconsin Comprehensive Cancer Center, Madison, WI 53792, USA.

PMID: 16622986
DOI: 10.1016/j.gassur.2005.08.026

No abstract available

PubMed Disclaimer

Similar articles

[Current status and therapeutic strategy for pancreatic neuroendocrine tumors in Japan].
Ito T, Igarashi H, Jensen RT, Takayanagi R. Ito T, et al. Fukuoka Igaku Zasshi. 2012 Jul;103(7):131-7. Fukuoka Igaku Zasshi. 2012. PMID: 22978065 Review. Japanese. No abstract available.
Novel Treatment Options for Neuroendocrine Tumors.
Kulke MH. Kulke MH. J Natl Compr Canc Netw. 2017 May;15(5S):737-739. doi: 10.6004/jnccn.2017.0088. J Natl Compr Canc Netw. 2017. PMID: 28515259
Systemic Therapies for Advanced Pancreatic Neuroendocrine Tumors.
Raj N, Reidy-Lagunes D. Raj N, et al. Hematol Oncol Clin North Am. 2016 Feb;30(1):119-33. doi: 10.1016/j.hoc.2015.09.005. Epub 2015 Oct 23. Hematol Oncol Clin North Am. 2016. PMID: 26614372 Free PMC article. Review.
Targeting neuroendocrine tumor: mixing standard options with novel therapies.
Raymond E, Dreyer C, Faivre S. Raymond E, et al. Target Oncol. 2012 Sep;7(3):151-2. doi: 10.1007/s11523-012-0231-z. Epub 2012 Aug 24. Target Oncol. 2012. PMID: 22918794 No abstract available.
[Drug therapy of advanced pancreatic neuroendocrine tumor].
Ristamäki R, Tarkkanen M. Ristamäki R, et al. Duodecim. 2016;132(7):641-6. Duodecim. 2016. PMID: 27188088 Review. Finnish.

See all similar articles

Cited by

Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases?
Hung JS, Chang MC, Lee PH, Tien YW. Hung JS, et al. World J Surg. 2007 Dec;31(12):2392-7. doi: 10.1007/s00268-007-9264-3. World J Surg. 2007. PMID: 17960455

References

1. Cancer. 2001 Apr 15;91(8):1543-8 - PubMed
1. Cancer. 1987 Dec 15;60(12):2891-5 - PubMed
1. Mol Cancer Ther. 2005 Jun;4(6):910-7 - PubMed
1. Cancer Chemother Pharmacol. 2004 Apr;53(4):337-40 - PubMed
1. Ann Oncol. 2001;12 Suppl 2:S111-4 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information